We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$237M
AUM Growth
-$12.4M
Cap. Flow
+$233M
Cap. Flow %
98.55%
Top 10 Hldgs %
40.76%
Holding
84
New
83
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$15.4M
2
BLUE
bluebird bio
BLUE
+$11.6M
3
BDX icon
Becton Dickinson
BDX
+$11.2M
4
SFR
Starwood Waypoint Homes
SFR
+$10.3M
5
OPTU
Optimum Communications Inc
OPTU
+$9.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 30.64%
2 Financials 21.74%
3 Real Estate 18.13%
4 Industrials 6.76%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
51
Aclaris Therapeutics
ACRS
$772M
$1.24M 0.52%
+45,740
New +$1.24M
BHVN
52
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.24M 0.52%
+49,390
New +$1.14M
LOXO
53
DELISTED
Loxo Oncology, Inc
LOXO
$1.2M 0.51%
+15,000
New +$831K
ESQ icon
54
Esquire Financial Holdings
ESQ
$1.12B
$1.13M 0.48%
+75,000
New +$1.13M
SGMO
55
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.1M 0.46%
+125,000
New +$802K
PACB icon
56
Pacific Biosciences
PACB
$441M
$1.07M 0.45%
+300,000
New +$1.21M
DERM
57
DELISTED
Dermira, Inc.
DERM
$1M 0.42%
+34,492
New +$1.05M
FBRX icon
58
Forte Biosciences
FBRX
$1.57B
$950K 0.4%
+211
New +$1.19M
RNTX
59
Rein Therapeutics
RNTX
$63.8M
$836K 0.35%
+3,750
New +$823K
DFIN icon
60
Donnelley Financial Solutions
DFIN
$1.2B
$804K 0.34%
+35,000
New +$766K
ATNX
61
DELISTED
Athenex, Inc. Common Stock
ATNX
$800K 0.34%
+2,500
New +$751K
GTHX
62
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$787K 0.33%
+45,110
New +$789K
CBIO
63
Crescent Biopharma
CBIO
$552M
$781K 0.33%
+700
New +$578K
BOC icon
64
Boston Omaha
BOC
$437M
$725K 0.31%
+55,000
New +$733K
NCSM icon
65
NCS Multistage Holdings
NCSM
$124M
$699K 0.3%
+1,387
New +$652K
EVBG
66
DELISTED
Everbridge, Inc. Common Stock
EVBG
$683K 0.29%
+28,055
New +$669K
ANAB icon
67
AnaptysBio
ANAB
$1.59B
$598K 0.25%
+25,000
New +$628K
URGN icon
68
UroGen Pharma
URGN
$1.88B
$594K 0.25%
+32,908
New +$571K
CASC
69
DELISTED
Cascadian Therapeutics, Inc.
CASC
$557K 0.24%
+150,000
New +$595K
SVRA icon
70
Savara
SVRA
$1.09B
$488K 0.21%
+83,012
New +$569K
HALO icon
71
Halozyme
HALO
$9.76B
$465K 0.2%
+36,254
New +$484K
WTTR icon
72
Select Water Solutions
WTTR
$2.29B
$452K 0.19%
+37,237
New +$531K
SEI
73
Solaris Energy Infrastructure
SEI
$3.4B
$410K 0.17%
+35,584
New +$403K
PENG
74
Penguin Solutions Inc
PENG
$2.7B
$400K 0.17%
+49,470
New +$375K
SCMP
75
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$368K 0.16%
+35,000
New +$357K
1 2
3
4

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
AAM
Ameraudi Asset Management New York $184M AUM 15.4% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
KWM
KMT Wealth Management El Segundo, California $184M AUM 17.2% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
TCM
Tassel Capital Management Matthews, North Carolina $184M AUM 17.12% 1-Year Est. Return

Monashee Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Monashee Investment Management held 84 positions worth $237M, down 5% from $249M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Monashee Investment Management deployed $233M of net new capital in Q2 2017, opening 83 new positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 300,000 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 19% a quarter earlier, followed by Financials and Real Estate.

  • Monashee Investment Management's largest Q2 2017 buy was Athene Holding Ltd. Class A Common Shares: 300,000 shares worth $14.9M.
  • Monashee Investment Management's ten largest holdings make up 41% of its $237M portfolio in Q2 2017.
  • Monashee Investment Management opened 83 new positions and closed 0 in Q2 2017.
  • Monashee Investment Management's portfolio value fell 5% quarter-over-quarter to $237M.

Based on Monashee Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.